Gelonghui October 28th | Sunflower Pharmaceutical Group (002737.SZ) announced its third quarter report for 2024, achieving revenue of 2.967 billion yuan in the first three quarters, a year-on-year decrease of 29.95%; net income attributable to shareholders of the listed company was 0.587 billion yuan, a year-on-year decrease of 31.06%; net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 0.46 billion yuan, a year-on-year decrease of 2.05%; basic earnings per share was 1.0 yuan.
葵花药业(002737.SZ)：前三季度净利润5.87亿元 同比下降31.06%
Sunflower Pharmaceutical Group (002737.SZ): The net income for the first three quarters was 0.587 billion yuan, a year-on-year decrease of 31.06%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated